| CHD patients | Healthy controls | P |
---|---|---|---|
 | n=60 | n=60 |  |
Age (years) | 60.42±8.75 | 61.09±8.87 | NS |
Male/Female | 44/16 | 42/18 | NS |
BMI (kg/m2) | 24.59±3.36 | 24.63±2.91 | NS |
Smoking cases (yes/no) | 38/22 | 36/24 | NS |
TG (mmol/L) | 1.75±0.91 | 1.33±0.68 | 0.041a |
TC (mmol/L) | 4.48±1.01 | 4.19±0.92 | NS |
HDL-C (mmol/L) | 1.04±0.29 | 1.20±0.28 | 0.018a |
LDL-C (mmol/L) | 2.78±1.10 | 2.24±0.71 | 0.036a |
FBS (mmol/L) | 6.49±3.06 | 5.94±2.79 | NS |
BUN (mmol/L) | 5.51±1.80 | 5.67±1.40 | NS |
Cr (umol/L) | 81.61±19.33 | 78.85±16.87 | NS |
ALT (mmol/L) | 24.68±9.99 | 20.58±8.21 | NS |
AST (mmol/L) | 26.79±9.45 | 24.24±7.44 | NS |
ACE inhibitor or ARB (%) | 36 (60%) | 0 (0%) | Â |
Beta-blocker (%) | 49 (82%) | 0 (0%) | Â |
Statin (%) | 60 (100%) | 0 (0%) | Â |
Aspirin (%) | 60 (100%) | 0 (0%) | Â |
Clopidogrel (%) | 15 (25%) | 0 (0%) | Â |